Advertisement

Von der Leyen says EU may restrict COVID-19 vaccine exports

European Commission President Ursula von der Leyen has said the EU may restrict vaccine exports t...
Newsroom
Newsroom

14.51 17 Mar 2021


Share this article


Von der Leyen says EU may rest...

Von der Leyen says EU may restrict COVID-19 vaccine exports

Newsroom
Newsroom

14.51 17 Mar 2021


Share this article


European Commission President Ursula von der Leyen has said the EU may restrict vaccine exports to countries outside the bloc.

The 27-nation region has been facing a shortage of coronavirus vaccines for some time.

President von der Leyen spoke as six EU countries complained about reduced deliveries that are hampering the bloc's troubled inoculation programme.

Advertisement

With the EU facing a third wave of the coronavirus pandemic and less than a tenth of its population vaccinated, President von der Leyen accused AstraZeneca of having "underproduced and underdelivered".

She warned she was "ready to use whatever tool we need" to ensure "Europe gets its fair share".

"We are in the crisis of the century," she said.

"If this situation does not change, we will have to reflect on how to make exports to vaccine-producing countries, dependent on their level of openness.

"We will reflect on whether exports to countries who have higher vaccination rates than us are still proportionate."

President von der Leyen said the EU has granted 314 requests for vaccine exports and has only refused one since authorisation was introduced on February 1st.

She said the flow of vaccines was smooth with the United States, but voiced frustration over lack of deliveries of the AstraZeneca vaccine from Britain.

"We are still waiting for doses to come from the UK," she said.

Meanwhile, as of Sunday, 617,050 doses of the COVID-19 vaccine have been administered in Ireland.

To date, more than 750,000 doses of the inoculation have been delivered here.

Of those, more than 200,000 are from AstraZeneca.

In a statement today, the World Health Organisation recommended that vaccines made by AstraZeneca continue to be administered, saying the benefits outweigh the risks.

Ireland is one of a dozen countries that have paused the rollout because of reports of blood clotting.

The European Medicines Agency is continuing to assess the safety of the vaccine before making a final decision tomorrow.

Main image: File photo of European Commission President Ursula von der Leyen. Credit: Johanna Geron/AP/Press Association Images

Share this article


Read more about

AstraZeneca Covid-19 Covid-19 Vaccines European Commission Ursula Von Der Leyen

Most Popular